Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2820 | 2064 | 41.3 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CD44 | Author keyword | 338 | 38% | 35% | 717 |
2 | CD44V6 | Author keyword | 94 | 61% | 5% | 99 |
3 | CD44 ISOFORMS | Author keyword | 90 | 96% | 1% | 27 |
4 | SOLUBLE CD44 | Author keyword | 50 | 88% | 1% | 23 |
5 | CD44S | Author keyword | 48 | 65% | 2% | 45 |
6 | CD44 VARIANTS | Author keyword | 38 | 78% | 1% | 25 |
7 | CD44V3 | Author keyword | 32 | 80% | 1% | 20 |
8 | CD44V | Author keyword | 21 | 85% | 1% | 11 |
9 | ANTIGENS CD44 | Author keyword | 18 | 83% | 0% | 10 |
10 | CD44 VARIANT ISOFORMS | Author keyword | 15 | 71% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CD44 | 338 | 38% | 35% | 717 | Search CD44 | Search CD44 |
2 | CD44V6 | 94 | 61% | 5% | 99 | Search CD44V6 | Search CD44V6 |
3 | CD44 ISOFORMS | 90 | 96% | 1% | 27 | Search CD44+ISOFORMS | Search CD44+ISOFORMS |
4 | SOLUBLE CD44 | 50 | 88% | 1% | 23 | Search SOLUBLE+CD44 | Search SOLUBLE+CD44 |
5 | CD44S | 48 | 65% | 2% | 45 | Search CD44S | Search CD44S |
6 | CD44 VARIANTS | 38 | 78% | 1% | 25 | Search CD44+VARIANTS | Search CD44+VARIANTS |
7 | CD44V3 | 32 | 80% | 1% | 20 | Search CD44V3 | Search CD44V3 |
8 | CD44V | 21 | 85% | 1% | 11 | Search CD44V | Search CD44V |
9 | ANTIGENS CD44 | 18 | 83% | 0% | 10 | Search ANTIGENS++CD44 | Search ANTIGENS++CD44 |
10 | CD44 VARIANT ISOFORMS | 15 | 71% | 1% | 12 | Search CD44+VARIANT+ISOFORMS | Search CD44+VARIANT+ISOFORMS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METASTASIS ASSOCIATED VARIANT | 256 | 91% | 5% | 105 |
2 | VARIANT ISOFORMS | 229 | 80% | 7% | 140 |
3 | HOMING RECEPTOR CD44 | 132 | 77% | 4% | 90 |
4 | HYALURONATE | 120 | 43% | 10% | 213 |
5 | LYMPHOCYTE HOMING RECEPTOR | 119 | 45% | 10% | 198 |
6 | HYALURONATE RECEPTOR | 67 | 80% | 2% | 41 |
7 | CONFER METASTATIC BEHAVIOR | 56 | 81% | 2% | 34 |
8 | SOLUBLE CD44 | 53 | 66% | 2% | 49 |
9 | HIGH ENDOTHELIUM | 44 | 67% | 2% | 40 |
10 | GLYCOPROTEIN CD44 | 44 | 72% | 2% | 34 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CD44: From adhesion molecules to signalling regulators | 2003 | 883 | 139 | 43% |
CD44: Structure, function, and association with the malignant process | 1997 | 426 | 365 | 63% |
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? | 2011 | 248 | 183 | 36% |
CD44 in cancer | 2002 | 220 | 270 | 74% |
CD44 cell adhesion molecules | 1999 | 199 | 107 | 83% |
A crucial role for CD44 in inflammation | 2001 | 241 | 74 | 55% |
CD44 in cancer progression: Adhesion, migration and growth regulation | 2004 | 214 | 313 | 54% |
Forms and functions of CD44 | 1998 | 135 | 109 | 83% |
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination | 2008 | 123 | 55 | 64% |
Perspectives of CD44 targeting therapies | 2015 | 3 | 121 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TUMOR PROG S IMMUNE DEF | 11 | 35% | 1.2% | 25 |
2 | ENDOCRINE UNIT 111N | 9 | 50% | 0.6% | 13 |
3 | DIFFERENCIAT HEMATOPOIET NORMALE LEUCEM | 3 | 100% | 0.1% | 3 |
4 | NEUROSURG OCULOCEREBROSPINAL INVEST | 3 | 100% | 0.1% | 3 |
5 | GIBH AFFILIATED FUDA HOSP | 3 | 60% | 0.1% | 3 |
6 | ENDOCRINE UNIT 111N2 | 2 | 67% | 0.1% | 2 |
7 | RD VIENNA | 2 | 67% | 0.1% | 2 |
8 | TUMOUR PROG S GRP | 2 | 67% | 0.1% | 2 |
9 | GENE REGULATSHINJUKU KU | 2 | 25% | 0.3% | 7 |
10 | BOEHRINGER INGELHEIM DEV | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000175018 | HYALURONAN//HYALURONAN SYNTHASE//RHAMM |
2 | 0.0000114705 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
3 | 0.0000047376 | CANCER STEM CELLS//CD133//CANCER STEM CELL |
4 | 0.0000047197 | ERRMECEEA 1391//GENET MED OBSTET GYNECOL//SCIRRHOUS GASTRIC CARCINOMA |
5 | 0.0000042070 | EZRIN//MOESIN//RADIXIN |
6 | 0.0000041391 | SELECTIN//L SELECTIN//SIALYL LEWIS X |
7 | 0.0000034360 | OSTEOPONTIN//OSTEOPONTIN OPN//OPN |
8 | 0.0000033285 | E CADHERIN//HEREDITARY DIFFUSE GASTRIC CANCER//PROPHYLACTIC GASTRECTOMY |
9 | 0.0000028947 | SOLUBLE ICAM 1//SICAM 1//SOLUBLE INTERCELLULAR ADHESION MOLECULE 1 |
10 | 0.0000026656 | SERBSKY SOCIAL FORENS PSYCHIAT//BRAIN ADJACENT TO TUMOR//BRAIN TUMOR TISSUE BANK |